{"id":"W4306639578","doi":"10.1080/14656566.2022.2135989","title":"Fedratinib: a pharmacotherapeutic option for JAK-inhibitor naïve and exposed patients with myelofibrosis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Extramedullary hematopoiesis; Clinical trial; Internal medicine; Bone marrow; Haematopoiesis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004138718,0.0002411033,0.0005711774,0.0002808775,0.0001904438,0.0008432395,0.0005301797,0.001127996,0.006333706],"category_scores_gemma":[0.001385781,0.00006273365,0.0005613083,0.000194761,0.0002360419,0.0005387476,0.0003511857,0.001406618,0.002087276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004074263,"about_ca_system_score_gemma":0.0005005324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004568068,"about_ca_topic_score_gemma":0.001545449,"domain_scores_codex":[0.999755,0.00007991504,0.00003421209,0.00003410238,0.00006278911,0.00003401287],"domain_scores_gemma":[0.9996129,0.0001388881,0.0001053702,0.000007913769,0.00009069734,0.00004437828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007829027,0.0001009994,0.001274986,0.004909406,0.0002047859,0.001193222,0.00007145409,0.0004695161,0.002424741,0.002446263,0.181794,0.8043276],"study_design_scores_gemma":[0.0009703104,0.0007105204,0.004729622,0.008221055,0.0004900917,0.007799007,0.0001659605,0.0009079625,0.001817997,0.005908268,0.9682294,0.00004974397],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01109334,0.8755913,0.002915014,0.07451645,0.004968509,0.0001319494,0.0007595064,0.0001899257,0.02983396],"genre_scores_gemma":[0.1333125,0.7734805,0.00404209,0.05887621,0.0140731,0.0002801001,0.001625116,0.00004981245,0.01426052],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006333706,"threshold_uncertainty_score":0.02118838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1012468145561539,"score_gpt":0.4063206045908273,"score_spread":0.3050737900346734,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}